Dexamethasone Sodium Phosphate Injection
Fresenius Kabi USA, LLC · Available
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 02/08/2019
- Package NDC
- 76045-210-10
- Generic name
- Dexamethasone Sodium Phosphate Injection
- Contact info
- 888-386-1300
- Availability
- Available
- Related info
- Check wholesalers for inventory
- Update date
- 09/15/2026
- Dosage form
- Injection
- Presentation
- Dexamethasone Sodium Phosphate, Injection, 4 mg/1 mL (NDC 76045-210-10)
- Company name
- Fresenius Kabi USA, LLC
- Status
- Current
- Therapeutic category
- Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Other, Pulmonary/Allergy, Rheumatology
- Harmonized identifiers (openFDA)
- Application number
- ANDA203129
- Brand name
- DEXAMETHASONE SODIUM PHOSPHATE
- Generic name
- DEXAMETHASONE SODIUM PHOSPHATE
- Manufacturer name
- Fresenius Kabi USA, LLC
- Product NDC
- 76045-210
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- INTRA-ARTICULAR, INTRALESIONAL, INTRAMUSCULAR, INTRAVENOUS, SOFT TISSUE
- Substance name
- DEXAMETHASONE SODIUM PHOSPHATE
- RxCUI
- 1812095
- SPL ID
- 9af24370-ee9f-4005-b1e9-96eef58fbde5
- SPL set ID
- ce25183b-cd67-4997-8de9-df59b750883b
- Package NDC
- 76045-210-00, 76045-210-10
- UNII
- AI9376Y64P